Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Mauger
Pennsylvania State Univ Hershey Med Ctr, Department: Public Health & Prev Medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
AstraZeneca
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Mauger discloses a potential conflict of interest in that he will be a paid consultant for AstraZeneca. He will provide scientific input for development of a new study protocol; if the new study moves forward, AstraZeneca would contract with SARP institutions, and Penn State may or may not be involved.
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)
RELEVANCE (See instructions): By integrating genetic, epigenetic, genomic and other approaches to identify pathobiologic processes and validate biomarkers that correlate over time with sub-phenotype progression, we expect to develop practical biomarker-based tools to predict loss of symptom control and risk of exacerbation. This will serve to ameliorate a part of the burden of Asthma, a disease which affects 22 million people in the United States.
Filed on January 18, 2017.
Tell us what you know about David Mauger's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “David Mauger”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Mauger | Boston Children's Hospital | Conflict of Interest | Novartis | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.